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Background/aim: In this single-center study, we aimed to analyze texture features of primary uterine lesions on 18F-FDG PET/CT to
predict lymph node metastases.
Material and methods: Totally, 157 (mean age: 62 ± 10.2 years) patients were included in the analysis. Histopathological examination
results were considered as the standard reference for nodal involvement. On 18F-FDG PET/CT images, only the primary tumor was
segmented. SUVmax, SUVmean, SUVpeak, MTV, and TLG of primary uterine lesions were calculated for analyses. For texture analysis
first, second, and higher-order texture features were calculated.
Results: Mean diameter of primary uterine lesions was calculated as 35± 18.1 mm. Lymph node metastases were detected in 19% of
patients in histopathological examination of surgical materials. While 26 patients had pelvic lymph node metastases, 19 patients had
additional paraaortic lymph node metastases. On radiomics analysis for 20 features, a significant difference was found between patients
with and without lymph node metastasis. With using data mining methods GLZLM ZLNU, EntropyGLCM, Entropyhisto, GLRLM LRHGE,
GLZLM HGZE, GLZLM SZHGE, GLRLM HGRE, GLRLM SRHGE were found significant radiomics features to predict lymph node
metastasis with a diagnostic accuracy of 0.8.
Conclusion: The radiomics analysis of intratumoral heterogeneity is a promising method for improving triage of the patients for lymph
node dissection in endometrial carcinoma.
Key words: Endometrial carcinoma, lymph node metastasis, 18F-FDG PET/CT, radiomics

1. Introduction
Endometrial carcinoma is the most common gynecological
cancer worldwide [1]. Lymph nodes are the most common
extrauterine spread site with the rate of 20% and the
presence of lymph node metastasis is a prognostic factor for
endometrial carcinoma patients [2,3]. Although surgery
including bilateral pelvic and paraaortic lymphadenectomy
is gold standard for nodal staging, the surgical management
of the nodal disease is still controversial [4,5]. Randomized
trials showed that pelvic lymphadenectomy had no impact
on survival in early-stage endometrial carcinoma patients
[6,7]. Considering the low rate of lymph node metastases,
determination of lymph node status preoperatively would
be beneficial for patient management to avoid surgeryrelated complications. In the last decade, sentinel lymph
node (SLN) mapping has become a feasible option
with high diagnostic accuracy in the management of
clinically early-stage endometrial cancer [8]. However,

the SLN algorithm suggests resection of only the mapped
nodes without systematic lymphadenectomy even if the
metastasis exists in the SLNs. Moreover, the status of SLNs
for metastasis will be reported in the postoperative period
and patients with SLN metastasis may have a need of a
second surgery for systematic lymphadenectomy. Another
limitation of SLN mapping is that it primarily focuses
on pelvic lymph nodes and evaluation of the paraaortic
area is not a standard. Thus, with this approach, isolated
paraaortic metastases can be under-diagnosed [9,10].
With its high positive predictive value, 18F-FDG PET/
CT is suggested as the best technique for endometrial
carcinoma nodal staging, particularly in high-risk patients
[11]. However, due to its low spatial resolution, metastatic
lymph nodes smaller than 5 mm result in false-negative
results [12]. Parameters reflecting the amount of 18F-FDG
uptake in the lymph node or in primary uterine lesion
have been studied. These were standardized uptake value
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(SUV) based parameters such as SUVmax, SUVpeak,
SUVmean as well as metabolic tumor volume (MTV)
and total lesion glycolysis (TLG) [12]. However, tumor
18
F-FDG uptake shows the uneven spatial distribution, at
least partly due to underlying biological tumor conditions
such as metabolism, hypoxia, necrosis, and cellular
proliferation, which is called intratumoral heterogeneity
[12]. One of the most highlighted methods to quantify
intratumoral heterogeneity from images is texture
analysis. Because intratumoral heterogeneity is related to
tumor aggressiveness, treatment response, and prognosis,
the relationship between texture features of primary tumor
focus, and lymph node metastases has been a subject of
interest. Recently, a few studies have focused on the value
of radiomics features of primary uterine tumors on PET
images to improve sensitivity in the detection of lymph
node metastases in patients with endometrial carcinoma
[13,14]. In this single-center study, we aimed to analyze
texture features of primary uterine lesions on 18F-FDG
PET/CT to predict lymph node metastases.
2. Material and methods
2.1. Patient population
In this study, 18F-FDG PET/CT images of 191 patients who
underwent surgical treatment for endometrial carcinoma
were evaluated retrospectively. The study was approved by
the local ethical committee (approval number: İ1-40-21).
Nineteen patients were excluded because their primary
tumors were non 18F-FDG avid. Additional 15 patients,
with a tumor smaller than 64 voxels were excluded from the
analysis. Finally, images of 157 patients were included in
the analysis. All the included patients had undergone total
hysterectomy, bilateral salpingo-oophorectomy, and at
least bilateral pelvic lymphadenectomy. Histopathological
examination results were considered as the standard
reference for nodal involvement.
2.2. 18F-FDG PET/CT protocol and tumor segmentation
All the patients underwent 18FDG PET/CT for evaluation
of the disease stage. Informed consent was obtained
from all patients before imaging. PET/CT images were
acquired with two PET/CT scanners, a GE Discovery ST
and Discovery 710 (GE Medical Systems, Milwaukee,
USA). Patients fasted at least 6 h before imaging and blood
glucose levels were checked. Those with a blood glucose
level above 150 mg/dL did not undergo scanning. Oral
contrast was given to all patients. Images from the vertex to
the proximal femur were obtained in the supine position.
Whole-body 18F-FDG PET/CT imaging was performed
approximately 1 h after intravenous injection of 296-370
MBq 18F-FDG. During the waiting period, patients rested
in a quiet room without taking any muscle relaxants. PET
images were acquired for 4 min per bed position. Emission
PET images were reconstructed with noncontrast CT

images. CT images were also obtained with a standardized
protocol of 140 kV, 70 mA, tube rotation time of 0.5 s
per rotation, a pitch of 6, and a slice thickness of 5 mm.
Patients were allowed to breathe normally during the
procedure. Attenuation-corrected PET/CT fusion images
were reviewed in three planes (transaxial, coronal, and
sagittal) on an AW VolumeShare 7 (GE Medical Systems,
Milwaukee, USA) workstation. A board-certified nuclear
medicine physician with more than 10 years’ experience
in PET/CT, segmented primary uterine lesions. 18F-FDG
PET/CT images were evaluated with a semiautomatic
approach. The volume of interest (VOI) of the uterine
lesion was defined on PET images with a threshold of 40%
of the maximum standardized uptake value (SUVmax)
using commercial software (PET VCAR; GE Healthcare).
Only the primary tumor was segmented. SUVmax,
SUVmean, SUVpeak, MTV, and TLG of primary uterine
lesions were calculated for analyses.
2.3. Texture feature extraction
Texture features (i.e. first-, second-, and higher-order
imaging parameters) were extracted using dedicated
software for radiomics (LIFEx) (https://www.lifexsoft.
org/ index.php). For technical reasons, second and higherorder imaging parameters were extracted only for lesions
greater than 64 voxels. Details of calculated first, second,
and higher-order texture features are given in Table 1. An
example of tumor delineation for texture analysis is given
in Figure 1.
2.4. Statistical analysis
WEKA 3.7 and SPSS 11.5 programs were used to evaluate
the data. Descriptives were presented as mean ± standard
deviation and median (minimum-maximum) for
quantitative variables and number of patients (percent)
for qualitative variables. In order to investigate whether
there is a statistically significant difference between
the qualitative variables with lymph node metastasis
positive and negative groups. Mann-Whitney U test was
used since the normal distribution assumptions were
not met. The statistical significance level was taken as
0.05. Classification methods of Support Vector Machine,
Hoeffding Tree, J48, and Multilayer Perceptron were
used in the WEKA program. The data set was evaluated
using the 10-fold cross-validation test option. Accuracy,
F-Measure, Precision, Recall, and Precision-Recall Curve
(PRC Area) were used as data mining performance criteria
of textural features of primary uterine tumors to predict
lymph node metastasis.
3. Results
3.1. Patients
Images of 157 (mean age: 62 ± 10.2 years) women who
underwent an 18F-FDG PET/CT scan with the diagnosis
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Table 1. List of the studied radiomics features.
The first-order

The higher-order

SUVmax

GLRLM SRE

SUVmean

GLRLM LRE

SUVpeak

GLRLM LGRE

MTV

GLRLM HGRE

TLG

GLRLM SRLGE

Skewness

GLRLM SRHGE

Kurtosis

GLRLM LRLGE

Entropyhisto

GLRLM LRHGE

Energy

GLRLM GLNU

SHAPE Sphericity

GLRLM RLNU

SHAPE Compacity

GLRLM RP
GLZLM SZE

The second-order

GLZLM LZE

Homogenity GLCM

GLZLM LGZE

Energy GLCM

GLZLM HGZE

Contrast GLCM

GLZLM SZLGE

Correlation GLCM

GLZLM SZHGE

Entropy GLCM

GLZLM LZLGE

Dissimilarity GLCM

GLZLM LZHGE
GLZLM GLNU
GLZLM ZLNU
GLZLM ZP
Coarseness NGLDM
Contrast NGLDM
Busyness NGLDM

SUV standardized uptake value, MTV metabolic tumor volume,
TLG total lesion glycolysis, GLCM gray-level cooccurence matrix,
GLRLM gray-level run-length matrix, SRE short-run emphasis,
LRE long-run emphasis, LGRE low gray-level run emphasis,
HGRE high gray-level run emphasis, SRLGE short-run low graylevel emphasis, SRHGE short-run high gray-level emphasis,
LRLGE long-run low gray-level emphasis, LRHGE long-run high
gray-level emphasis, GLNU gray-level nonuniformity, RP run
percentage, GLZLM gray level zone length matrix, SZE shortzone emphasis, LZE long-zone emphasis, LGZE low gray-level
zone emphasis, HGZE high gray-level zone emphasis, SZLGE
short-zone low gray-level emphasis, SZHGE short-zone high
gray-level emphasis, LZLGE long-zone low gray-level emphasis,
LZHGE long-zone high gray-level emphasis, ZLNU zone length
nonuniformity, ZP zone percentage, NGLDM neighborhood
grey-level different matrix.

of endometrial carcinoma between March 2012 and
July 2019 were analyzed. Details of the study population
are presented in Table 2. The mean diameter of primary
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uterine lesions was calculated as 35 ± 18.1 mm. Lymph
node metastases were detected in 30 (19%) of patients in
histopathological examination of surgical materials. While
26 patients had pelvic lymph node metastases, 19 patients
had paraaortic lymph node metastases.
3.2. Texture analysis of 18F-FDG PET images and data
mining
Descriptive data of texture parameters for lymph node
metastasis positive and negative patient groups are
provided in Table 3. On radiomics analysis for 20 features,
a significant difference was found between patients with
and without lymph node metastasis.
Information Gain Attribute Eval and Gain Ratio
Attribute Eval methods in WEKA were used because there
were too many variables in the data set. With using these
methods, the importance of the variables and the values it
added to the data set were examined. The variables, which
were determined to be insignificant by two methods and
considered to be unimportant as clinical information,
were excluded from the data set. A total of 9 variables (8
independent variables and 1 dependent variable) remained
finally. These variables were GLZLM ZLNU, EntropyGLCM,
Entropyhisto, GLRLM LRHGE, GLZLM HGZE, GLZLM
SZHGE, GLRLM HGRE, GLRLM, SRHGE, and lymph
node metastases. Percentages of variable importance
according to dependent variable lymph node metastases
are given in Figure 2.
Looking at the data mining results in Table 4, the
Support Vector Machine, Hoeffding Tree, and J48 gave
similar results according to Accuracy and F-measure
criteria, which are the most accepted performance criteria.
Multilayer perceptron was found to be the worst serving
method. The diagnostic accuracy of texture parameters
was calculated at about 0.8 for the prediction of lymph
node metastasis.
4. Discussion
Due to the limited spatial resolution of 18F-FDG PET,
metastatic lymph nodes smaller than 5 mm cannot be
diagnosed accurately and this can cause false-negative
findings [11]. In this study, we aimed to investigate the
efficacy of radiomics analysis of the primary uterine lesion
to improve the sensitivity of 18F-FDG PET in detecting
nodal metastases. We analyzed standard imaging features
like SUV, MTV, and TLG, together with the first, second,
and higher-order texture features.
The concept of radiomics is defined as the highthroughput extraction of a large number of features from
medical images [15,16]. It is assumed that genomic and
proteomic cancer patterns are expressed in image-based
features and with optimal analysis of medical images such
as texture analysis, cancer properties can be quantified
[12,16]. Texture analysis has long been applied in CT
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Figure 1. An example for tumor delineation for texture analysis.

and magnetic resonance imaging (MRI), but it has been
adapted to PET imaging very recently [14]. As the most
widely used PET feature; SUVmax of primary uterine
lesions, is considered as an important indicator reflecting
tumor aggressiveness, such as myometrial invasion or
tumor grade. However, it was not significantly correlated
with lymph node status according to previous studies
[17,18]. Contrarily to SUVmax other semiquantitative
parameters, MTV and TLG seem to have a predictive role
for lymph node status. Endometrial tumors with higher
MTV and TLG have a higher tendency to spread to lymph
nodes than without [19].
In our analyses, descriptive parameters of SUVpeak,
MTV, and TLG of patients with and without lymph node
metastasis were found significantly different. However,
they did not remain significant in the data mining methods.
In the data mining methods, one first, one second, and six
higher-order texture parameters were found significant to
predict lymph node metastases. GLZLM ZLNU showed
the best performance for nodal staging in data mining.
It is a higher-order texture feature and is described as the
length of the homogeneous zones in the gray level zone
length matrix. It has been reported as the best texture

parameter for discrimination of squamous cell carcinoma
and adenocarcinoma of the lung [20]. Similarly, patients
with estrogen negative breast tumors were reported higher
GLZLM ZLNU than positive ones [21]. Moreover, Wang
et al. published prognostic value of functional parameters
of 18F-FDG PET/CT in patients with renal/adrenal
lymphoma. They have reported that the tumor stage,
Entropy GLCM, GLZLM GLNU, and GLZLM ZLNU values
were significant predictors of overall survival [22]. Entropy
which is described as the randomness of grey-level
GLCM
voxel pairs was the second most significant texture feature
in our series.
When we take a look at the PET radiomics studies
in endometrial carcinoma patients, data is limited in the
literature [13,14]. Bernardi et al. reported their data for
texture analysis of 18F-FDG PET images of endometrial
carcinoma patients. They found that the zone percentage
of the grey level size zone matrix, (GLSZM ZP) was able to
predict LN metastases better than any other feature. Also,
they reported that the combination of visual detection and
GLSZM ZP values increased the sensitivity of lymph node
metastasis detection [13]. In another study, Crivellaro et
al. reported the results of the combination of PET/CT,
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Table 2. Characteristics of the patient population.
Parameter
Age (mean ± SD, years)

62.0 ± 10.2

Menopausal state (n,%)
Premenopausal

25 (15.9%)

Postmenopausal

132 (84.1%)

Grade (n,%)
G1

44 (28.0%)

G2

56 (35.6%)

G3

57 (36.4%)

Histology (n, %)
Endometrioid

124 (79.0%)

Clear cell/serous/mucinous/mixed

21 (13.4%)

Malignant mesodermal tumor

12 (7.6%)

Myometrial invasion (n %)
None

11 (7.0%)

<50%

74 (47.1%)

>50%

72 (45.9%)

FIGO Stage (n, %)
I

112 (71.3%)

II

12 (7.6%)

III

26 (16.6%)

IV

7 (4.5%)

Lymph node metastases (n,%)
Yes

30 (19.1%)

No

127 (80.9%)

FIGO: Federation of Gynecology and Obstetrics

radiomics, and sentinel lymph node mapping for nodal
staging of endometrial cancer patients. They found a
significant association between the presence of lymph node
metastases and 64 features on radiomics analysis. Volumedensity was the most predictive feature. They concluded
that PET radiomics features of the primary tumor seemed
promising for the prediction of nodal metastases, which
were not detected by visual analysis [14]. In endometrial
carcinoma patients, different radiomics features have been
reported as the best predictor for lymph node metastases.
That might be related to the limited number of included
patients and the different distribution of risk groups
between studies. In our study, differently from previous
ones, we used cross-validation method for data mining.
Cross-validation is the recommended method for analyzing
all data with more precise metrics [23]. Although different
texture features showed significant distribution among
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patients with and without lymphatic metastases, results
of our analysis and previously reported ones support the
idea that radiomics analysis of PET images of primary
uterine lesions is a promising method to define lymph
node metastasis. Standardized, randomized studies with
large patient populations would help validation of texture
features to predict lymph node metastasis of endometrial
carcinoma.
In routine clinical practice, lymphadenectomy decision
is given according to risk factors-grade, myometrial
invasion and tumor type- provided by preoperative
endometrial biopsy or intraoperative frozen section
examination. However, unnecessary lymphadenectomy
is still possible for many patients despite the use of these
methods. Instead of this approach, the SLN algorithm
seems to be a more convenient method, but low volume
metastases are also diagnosed by the SLN ultrastaging
procedure, and the sensitivity of 18F-FDG PET CT in the
diagnosis of lymphatic metastases decreases. With the
combined use of radiomics and SLN mapping [14], patients
who are candidates for SLN mapping and ultrastaging can
be determined, even for low-volume disease, and patients
at risk for lymphatic metastasis can be more accurately
identified. We planned to investigate the diagnostic
accuracy of a combination of SLN mapping and radiomics
in another study.
This study is one of the very few studies evaluating
radiomics in endometrial cancer, and our results may
guide future studies. However, the retrospective design
and the small number of patients were the major
limitations of our study. Although we have not correlated
oncologic outcomes with radiomics analysis, future
studies may show a correlation of these two features and
this knowledge could help clinicians in planning patientbased treatment and follow-up protocols. In this study, we
analyzed data of two different PET/CT scanners. It should
be kept in mind that accurate results cannot be achieved
in the data of two different PET/CT scanners, even if they
were performed using the same protocol. Since this may
cause heterogeneity in the images and the results obtained.
Another limitation of the study is that the radiomics
analysis results in combination with SLN mapping are
missing. Lastly, dealing with high data input made results
technically complex. As the studies come across, several
models would be created, and this complex situation could
then be overcome.
5. Conclusion
The radiomics analysis of intratumoral heterogeneity is
a promising method for improving triage of the patients
for lymph node dissection in endometrial carcinoma.
However, multicenter studies with larger patient
populations are needed for validation.
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Table 3. Descriptives for lymph node metastases.

Variables

Lymph node metastasis
No (n = 127)
Mean ± SD

Yes (n = 30)
Median
(min-max)
9 June

Mean ± SD

th

SUVpeak

8.88 ± 7.81

TLG

115.81 ± 180.55

Entropyhisto

1.19 ± 0.21

Energy

0.09 ± 0.10

MTV

11.55 ± 13.83

Energy GLCM

0.02 ± 0.03

Contrast GLCM

57.29 ± 52.40

Correlation GLCM

0.17 ± 0.15

Entropy GLCM

1.61 ± 0.84

Dissimilarity GLCM

4.98 ± 3.20

GLRLM HGRE

849.27 ± 891.45

GLRLM SRHGE

803.31 ± 814.99

GLRLM LRHGE

1332.78 ± 3300.98

GLRLM GLNU

15.45 ± 29.84

GLRLM RLNU

174.91 ± 229.61

GLZLM HGZE

822.53 ± 816.52

GLZLM SZHGE

630.12 ± 660.65

GLZLM LZHGE

102,276.19 ± 903,259.46

(0.00–30.28)
45.55
(5.13–1227.41)
January 22
(0.00–1.58)
0.07
(0.03–1.00)
June 18
(0.52–85.00)
0.01
(0.00–0.34)
47.50
(0.00–228.46)
0.16
(–0.10–0.58)
January 84
(0.00–2.75)
May 43
(0.00–12.14)
550.55
(0.00–3446.93)
536.24
(0.00–3044.55)
609.35
(0.00–34583.96)
August 25
(0.00–279.51)
108.71
(0.00–1453.19)
564.47
(0.00–3153.00)
382.74
(0.00–2444.10)
2686.92
(0.00–10,085,856.18)

12.83 ± 7.35
300.17 ± 418.73
1.28 ± 0.25
0.09 ± 0.09
25.11 ± 29.59
0.02 ± 0.06
73.94 ± 43.28
0.28 ± 0.18
2.10 ± 0.69
6.26 ± 2.52
1325.28 ± 825.50
1245.22 ± 707.57
2118.29 ± 3716.78
21.64 ± 21.04
376.92 ± 390.69
1294.76 ± 751.74
984.46 ± 627.32
116,072.17 ±
578,882.13

Median

p value

(min-max)
15.13

0.008

(0.00–27.67)
156.97

<0.001

(9.21–2209.97)
January 36

0.002

(0.60–1.57)
0.05

0.007

(0.03–0.47)
14.29

<0.001

(2.01–150.60)
0.01

0.037

(0.00–0.34)
66.39

0.032

(0.00–174.36)
0.24

0.004

(0.00–0.63)
February 24

<0.001

(0.00–2.82)
June 29

0.036

(0.00–10.72)
1337.62

0.001

(0.00–3584.94)
1294.08

0.002

(0.00–2630.25)
1472.90

0.001

(0.00–21,168.33)
14th June

0.014

(0.00–84.61)
242.75

0.001

(0.00–1778.01)
1339.45

0.001

(0.00–3164.98)
980.51

0.002

(0.00-2828.95)
6288.71

0.005

(0.00–3,179,985.77)
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Table 3. (Continued).
GLZLM GLNU
GLZLM ZLNU

6.17 ± 6.96
54.79 ± 68.57

4th July

10.84 ± 9.47

(0.00–36.85)
30.25

115.81 ± 111.29

(0.00–361.54)

August 34

0.002

(0.00–43.27)
95.10

<0.001

(0.00–566.81)

SUV standardized uptake value, MTV metabolic tumor volume, TLG total lesion glycolysis, GLCM gray-level cooccurence matrix,
GLRLM gray-level run-length matrix, HGRE high gray-level run emphasis, SRHGE short-run high gray-level emphasis, LRHGE longrun high gray-level emphasis, GLNU gray-level nonuniformity, HGZE high gray-level zone emphasis, SZHGE short-zone high graylevel emphasis, LZHGE long-zone high gray-level emphasis, ZLNU zone length nonuniformity.

Figure 2. Variable importance for metastases.
Table 4. Performance comparison of data mining methods.
Methods

F-Measure

Precision

Recall

PRC Area

Support vector machine

0.723

0.655

0.808

0.691

Hoeffding Tree

0.723

0.655

0.808

0.688

J48

0.731

0.720

0.803

0.701

Multilayer perceptron

0.736

0.716

0.771

0.745
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